Otto Warburg, M.D., was awarded the Nobel Prize for his discovery that the cancer cell uses an anaerobic energy cycle, meaning it does not depend upon oxygen to sustain itself. This more primitive method of energy production found in cancer cells uses a fermentation cycle which requires more glucose than a normal cell. An enormous amount of the waste product, lactic acid, is produced in this kind of energy production. Because of the great glucose needs of the cancer cell, the liver is stimulated by messages from the cancer cells to utilize an enzyme to convert the lactic acid waste back into more glucose.
 

Oral administration of hydrazine sulfate blocks that enzyme from doing its job in the liver and the lactic acid remains lactic acid. These findings were originally authenticated by Dr. Gold, then Director of the National Cancer Research Center. Dr. Gold was fired as the director of the N. C. R. C. shortly after publishing his discovery of such a simple and un-patentable treatment. (All research centers live on grants and you can’t get grant money if your research develops a non-patentable product!)

Hydrazine sulfate is a chemical that may reverse the effects of cachexia, which is a state of poor nutrition within the human body. The reversal could enable the patient to ultimately resist the attacks of cancer by strengthening the body. However, hydrazine sulfate is not characterized as a cure even though the chemical is known to shrink as well as destroy cancerous tumors completely at each stage.

Over the course of fifteen years, scientists at Leningrad's Petrov Research Institute of Oncology conducted an experiment in which seven hundred and forty terminal cancer patients were observed in order to discover the effectiveness of hydrazine sulfate therapy. In the experiment, the scientists observed a cachexia improvement within almost fifty percent of the patients, in which fourteen percent benefited substantially. Furthermore, the scientists observed a stable cancerous state within one-hundred percent of the patients, and they saw a regression in the tumors within ten percent.

Even though patients often benefit to hydrazine sulfate therapy by gaining weight, the chemical may be harmful to one's health. Hydrazine sulfate therapy induces nausea, dizziness, itching, drowsiness, and euphoria(a state in which a person feels extreme levels of happiness). Extremity numbness has also occurred; however, this condition may be reduced by consuming B6.